1. Musetti, Sara N, Huang, Leaf. 2021. Tinagl1 Gene Therapy Suppresses Growth and Remodels the Microenvironment of Triple Negative Breast Cancer. In Molecular pharmaceutics, 18, 2032-2038. doi:10.1021/acs.molpharmaceut.1c00008. https://pubmed.ncbi.nlm.nih.gov/33877834/
2. Shen, Minhong, Jiang, Yi-Zhou, Wei, Yong, Shao, Zhi-Ming, Kang, Yibin. 2019. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. In Cancer cell, 35, 64-80.e7. doi:10.1016/j.ccell.2018.11.016. https://pubmed.ncbi.nlm.nih.gov/30612941/
3. Shan, Zhi-Guo, Sun, Zhen-Wei, Zhao, Li-Qun, Zhuang, Yuan, Zhao, Yong-Liang. 2020. Upregulation of Tubulointerstitial nephritis antigen like 1 promotes gastric cancer growth and metastasis by regulating multiple matrix metallopeptidase expression. In Journal of gastroenterology and hepatology, 36, 196-203. doi:10.1111/jgh.15150. https://pubmed.ncbi.nlm.nih.gov/32537806/
4. Deng, Yufei, Liu, Lifeng, Xiao, Xia, Zhao, Yin. 2023. A four-gene-based methylation signature associated with lymph node metastasis predicts overall survival in lung squamous cell carcinoma. In Genes & genetic systems, 98, 209-219. doi:10.1266/ggs.22-00111. https://pubmed.ncbi.nlm.nih.gov/37839873/
5. Khashei Varnamkhasti, Khalil, Moghanibashi, Mehdi, Naeimi, Sirous. 2024. Implications of ZNF334 gene in lymph node metastasis of lung SCC: potential bypassing of cellular senescence. In Journal of translational medicine, 22, 372. doi:10.1186/s12967-024-05115-9. https://pubmed.ncbi.nlm.nih.gov/38637790/